Literature DB >> 14972512

Aberrant expression and possible involvement of the leptin receptor in bladder cancer.

Shyng-Shiou F Yuan1, Yueh-Fang Chung, Hsiao-Wen Chen, Kun-Bow Tsai, Hsueh-Ling Chang, Chun-Hsiung Huang, Jinu-Huang Su.   

Abstract

OBJECTIVES: To explore the expression patterns and possible involvement of leptin and its receptor in the pathogenesis of urinary bladder cancer, with a focus on transitional cell carcinoma.
METHODS: Using reverse transcription-polymerase chain reaction, immunoblotting, and immunohistochemistry techniques, we correlated the expression patterns of leptin and its receptor with the occurrence of transitional cell carcinoma. We also applied transient transfection followed by BrdU labeling and immunofluorescent staining to address the effect of the leptin receptor on bladder cancer cell growth.
RESULTS: Although leptin was not detected in the bladder tissue specimens, a decreased expression of the leptin receptor was observed in most cancer tissue specimens we analyzed. Furthermore, the forced expression of the leptin receptor in T24 bladder cancer cells prevented them from entering the S phase.
CONCLUSIONS: Our data demonstrated for the first time that the leptin receptor is aberrantly expressed in bladder cancer tissue and is possibly involved in the carcinogenesis of bladder cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972512     DOI: 10.1016/j.urology.2003.08.038

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  8 in total

Review 1.  Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells.

Authors:  Shanchun Guo; Mingli Liu; Guangdi Wang; Marta Torroella-Kouri; Ruben R Gonzalez-Perez
Journal:  Biochim Biophys Acta       Date:  2012-01-24

2.  The role of leptin receptor gene polymorphisms in determining the susceptibility and prognosis of NSCLC in Chinese patients.

Authors:  Yuliang Li; Jianli Geng; Yongzheng Wang; Qinghua Lu; Yimeng Du; Wujie Wang; Zheng Li
Journal:  J Cancer Res Clin Oncol       Date:  2011-11-30       Impact factor: 4.553

3.  Defective ribosomal protein gene expression alters transcription, translation, apoptosis, and oncogenic pathways in Diamond-Blackfan anemia.

Authors:  Hanna T Gazda; Alvin T Kho; Despina Sanoudou; Jan M Zaucha; Isaac S Kohane; Colin A Sieff; Alan H Beggs
Journal:  Stem Cells       Date:  2006-06-01       Impact factor: 6.277

4.  Phenotypic effects of an induced mutation of the ObRa isoform of the leptin receptor.

Authors:  Zhiying Li; Giovanni Ceccarini; Michael Eisenstein; Keith Tan; Jeffrey Michael Friedman
Journal:  Mol Metab       Date:  2013-08-04       Impact factor: 7.422

5.  Primary study of leptin and human hepatocellular carcinoma in vitro.

Authors:  Jing Zhou; Wei Lei; Lei Shen; He-Sheng Luo; Zhi-Xiang Shen
Journal:  World J Gastroenterol       Date:  2008-05-14       Impact factor: 5.742

6.  Investigation of Leptin G19A polymorphism with bladder cancer risk: A case-control study.

Authors:  Fei Mao; Xiao-Bing Niu; Shuo Gu; Lu Ji; Bing-Jian Wei; Heng-Bing Wang
Journal:  J Clin Lab Anal       Date:  2020-05-03       Impact factor: 2.352

7.  Vitamin D, obesity and leptin in relation to bladder cancer incidence and survival: prospective protocol study.

Authors:  Randi Elin Gislefoss; Jo Steinson Stenehjem; Helga Helseth Hektoen; Bettina Kulle Andreassen; Hilde Langseth; Karol Axcrona; Elisabete Weiderpass; Alison Mondul; Trude Eid Robsahm
Journal:  BMJ Open       Date:  2018-03-30       Impact factor: 2.692

8.  The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer.

Authors:  Alina Vrieling
Journal:  Transl Androl Urol       Date:  2018-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.